Deoxymab 3E10 is the world’s first cell-penetrating anti-DNA antibody for the potential treatment of
cancer and has the prospect of revolutionising treatment across a broad range of cancers
Ann: Chairman's Address and CEO Presentation to 2019 AGM, page-3
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.201M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $455 | 130K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 30295209 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 22489307 | 15 |
View Market Depth
| Last trade - 10.36am 09/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |